Pasinex Logo.png
Pasinex Provides Update on Status of MCTO and Interim Filings
28 mai 2024 18h51 HE | Pasinex Resources Limited
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- May 28, 2024 - Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (the “Company” or “Pasinex”), is providing a further update on the status of a voluntary...
Pro Kapitali nõukogu
Pro Kapitali nõukogu kinnitas 2024. a I kvartali ja 3 kuu konsolideeritud vahearuande (auditeerimata)
28 mai 2024 03h45 HE | Pro Kapital Grupp
  TEGEVUSARUANNE Kinnisvaraarendus 2024. aastal jätkame Kalaranna 8 arenduse viimase etapi ehituse ja müügiga. Viimane etapp koosneb 4-st kortermajast 146 korteri ja 4 äripinnaga,...
Pro Kapital Council
Pro Kapital Council approved Consolidated Interim Report for I Quarter and 3 Months of 2024 (Unaudited)
28 mai 2024 03h45 HE | Pro Kapital Grupp
  MANAGEMENT REPORT Real Estate Development In 2024, we are continuing the construction and sales activities of the last stage of Kalaranna 8, Tallinn. The final stage consists of 4...
Pro Kapital Council
Pro Kapital Council approved Consolidated Interim Report for I Quarter and 3 Months of 2024 (Unaudited)
28 mai 2024 03h45 HE | Pro Kapital Grupp
  MANAGEMENT REPORT Real Estate Development In 2024, we are continuing the construction and sales activities of the last stage of Kalaranna 8, Tallinn. The final stage...
UAB "Partnerystės pr
UAB "Partnerystės projektai keturi" 2024 metų pirmo ketvirčio finansinės ataskaitos
28 mai 2024 02h41 HE | UAB PARTNERYSTĖS PROJEKTAI KETURI
UAB „Partnerystės projektai keturi“ (toliau – Emitentas) praneša apie pateiktas finansines ataskaitas už 3 mėnesių laikotarpį, pasibaigusį 2024 m. kovo 31 d. Kaip buvo pranešta 2024 m. balandžio...
UAB Partnerystės pro
UAB Partnerystės projektai keturi 2024 first quarter financial statements
28 mai 2024 02h41 HE | UAB PARTNERYSTĖS PROJEKTAI KETURI
UAB Partnerystės projektai keturi ("the Issuer") has issued its financial statements for the 3-month period ended 31 March 2024. As announced on 8 April 2024, the Project has been successfully...
MnM_logo_TM_JPG.JPG
Liquid Biopsy Market is Expected to Reach $11.3 billion | MarketsandMarkets™
27 mai 2024 08h30 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 27, 2024 (GLOBE NEWSWIRE) -- Liquid Biopsy market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of...
2024 m. I ketvirčio
2024 m. I ketvirčio AB „Kauno energija“ ūkinės veiklos rezultatai
24 mai 2024 09h00 HE | AB "Kauno energija"
2024 m. gegužės 24 d. AB „Kauno energija“ (toliau – Bendrovė) (įm. kodas 235014830) valdyba įvertino Bendrovės 2024 m. I ketvirčio ūkinės veiklos rezultatus ir finansinę padėtį 2024 m. kovo 31 dienai...
Activity results of
Activity results of AB Kauno energija of the 1 quarter of the year 2024
24 mai 2024 09h00 HE | Kauno energija
The Management Board of AB Kauno Energija (hereinafter – the Company) (code – 235014830) assessed the results of Company’s business activity of the 1 quarter of the year 2024 and financial state as at...
MnM_logo_TM_JPG.JPG
Veterinary Reference Laboratory Market is Expected to Reach $7.8 billion | MarketsandMarkets™
24 mai 2024 08h30 HE | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 24, 2024 (GLOBE NEWSWIRE) -- Veterinary Reference Laboratory market in terms of revenue was estimated to be worth $4.6 billion in 2024 and is poised to reach $7.8 billion by 2029,...